Literature DB >> 30250134

Exercise training and/or diet on reduction of intra-abdominal adipose tissue and risk factors for cardiovascular disease.

Juliano H Borges1,2, Stephen J Carter3, David R Bryan3, Gary R Hunter3.   

Abstract

BACKGROUND/
OBJECTIVES: To test the effects of weight loss with and without exercise training (aerobic or resistance) on intra-abdominal adipose tissue (IAAT) and risk factors for cardiovascular disease (CVD). Additionally, CVD risk factors was evaluated before and after weight loss using previously established IAAT cut-points. SUBJECTS/
METHODS: One hundred twenty-two overweight premenopausal women were randomly assigned to one of three groups: (1) diet only (Diet); (2) diet and aerobic training (Diet + AT); or (3) diet and resistance training (Diet + RT); until a BMI of < 25 kg/m2 was reached. Computerized tomography was used to measure IAAT and blood lipids were measured by assay. Evaluations were made before and after weight loss.
RESULTS: Though no group-by-time effects were found after weight loss, we observed significant time effects for: IAAT (-38.0%, P < 0.001), total cholesterol (TC) (-2.2%, P = 0.008), low-density lipoprotein cholesterol (LDL-C) (-4.8%, P < 0.001), high-density lipoprotein cholesterol (HDL-C) (+20.2%, P < 0.001), triglycerides (-18.7%, P < 0.001), TC/HDL-C (-16.3%, P < 0.001), and LDL-C/HDL-C (-18.0%, P < 0.001). Following weight loss, 40.2% of all participants reduced IAAT to < 40 cm2 (IAAT associated with low CVD risk). Furthermore, only 2.5% of participants had an IAAT > 110 cm2 (IAAT associated with high CVD risk) after weight loss. We also observed that decreases of IAAT were associated with decreased CVD risk factors after weight loss independent of race, changes in %fat mass and changes in maximal oxygen uptake.
CONCLUSIONS: Caloric restriction leading to significant weight loss with or without exercise training appears to be equally effective for reducing IAAT and CVD risk factors.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30250134      PMCID: PMC8230735          DOI: 10.1038/s41430-018-0318-4

Source DB:  PubMed          Journal:  Eur J Clin Nutr        ISSN: 0954-3007            Impact factor:   4.016


  4 in total

1.  Intra-abdominal adipose tissue cut-points related to elevated cardiovascular risk in women.

Authors:  M J Williams; G R Hunter; T Kekes-Szabo; M S Trueth; S Snyder; L Berland; T Blaudeau
Journal:  Int J Obes Relat Metab Disord       Date:  1996-07

2.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

Authors:  W T Friedewald; R I Levy; D S Fredrickson
Journal:  Clin Chem       Date:  1972-06       Impact factor: 8.327

3.  Visceral adiposity and its anatomical distribution as predictors of the metabolic syndrome and cardiometabolic risk factor levels.

Authors:  Ellen W Demerath; Derek Reed; Nikki Rogers; Shumei S Sun; Miryoung Lee; Audrey C Choh; William Couch; Stefan A Czerwinski; W Cameron Chumlea; Roger M Siervogel; Bradford Towne
Journal:  Am J Clin Nutr       Date:  2008-11       Impact factor: 7.045

Review 4.  Lipoprotein ratios: Physiological significance and clinical usefulness in cardiovascular prevention.

Authors:  Jesús Millán; Xavier Pintó; Anna Muñoz; Manuel Zúñiga; Joan Rubiés-Prat; Luis Felipe Pallardo; Luis Masana; Alipio Mangas; Antonio Hernández-Mijares; Pedro González-Santos; Juan F Ascaso; Juan Pedro-Botet
Journal:  Vasc Health Risk Manag       Date:  2009-09-18
  4 in total
  2 in total

Review 1.  Comparisons of calorie restriction and structured exercise on reductions in visceral and abdominal subcutaneous adipose tissue: a systematic review.

Authors:  Takashi Abe; Jun Seob Song; Zachary W Bell; Vickie Wong; Robert W Spitz; Yujiro Yamada; Jeremy P Loenneke
Journal:  Eur J Clin Nutr       Date:  2021-05-26       Impact factor: 4.016

Review 2.  Adipose Tissue Distribution, Inflammation and Its Metabolic Consequences, Including Diabetes and Cardiovascular Disease.

Authors:  Alan Chait; Laura J den Hartigh
Journal:  Front Cardiovasc Med       Date:  2020-02-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.